Delivery Order SPE2DB20D3103-SPE2DB24FM2C3
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Herceptin 150 mg vials. The $2,650.59 firm fixed-price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen, through its Corporate Office division, will provide these critical oncology medications to support military treatment facilities and other government healthcare programs. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,681.68 firm fixed-price contract is for the delivery of 4,567,615,883 units of Herceptin 150 mg vials. The contract has an ultimate completion date of April 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,068.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide HERCEPTIN 150 MG VIALS. The delivery order is part of Amerisourcebergen Drug Corp's larger, single-award indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
- The U.S. government has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,942,502 units of Herceptin 150 mg vials. The contract has a ceiling value of $8,835.30 and a period of performance through April 2, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense's military treatment programs and facilities. Amerisourcebergen Drug...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,650.59 contract is for the delivery of 150 mg vials of the cancer drug Herceptin. The contract has a completion date of June 28, 2024 and is a firm fixed price, delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $2,650.59 firm fixed-price delivery order is for the supply of 150 mg vials of the drug Herceptin. The contract has an ultimate completion date of November 5, 2024 and was awarded on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,583.08, is for the delivery of 4,568,175,562 units of the prescription drug Herceptin 150 mg vials. The contract is a firm fixed-price delivery order with a completion date of May 29, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the procurement of HERCEPTIN 150 MG VIALS. The contract has a ceiling value of $26,704.20 and is a firm fixed price delivery order with an ultimate completion date of April 29, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Herceptin 150 mg vials. The contract has a firm fixed price of $21,937.68 and an ultimate completion date of January 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- The Defense Logistics Agency awarded a $21,363.36 delivery order to AmerisourceBergen Drug Corp for 150 mg Herceptin vials, with a completion date of September 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. Herceptin (trastuzumab) is a monoclonal antibody used in cancer treatment, particularly for HER2-positive breast cancer cases, making this a critical pharmaceutical supply...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM2C3Delivery Order
This contract award to AmerisourceBergen Drug Corp is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC). The $17,670.60 firm fixed-price contract is for the delivery of Herceptin 150 mg vials, a specialty pharmaceutical used to treat certain types of breast cancer. The contract has an ultimate completion date of January 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 IDC with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential medical and pharmaceutical items for military personnel, veterans, and other federal beneficiaries. The contract award reviewed does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 1/9/24 |